OBJECTIVE {#sec1-1}
=========

1.  To review recent scientific advances in exercise testing methods and results that is important for a clinical practioner.

2.  To understand the utility and limitations of different methods of exercise testing.

3.  To understand appropriate method in assessment and management of patients.

4.  To appreciate that exercise testing results can have greater clinical meaning when interpreted in context of relevant patient information.

5.  To understand that additional study is required to further characterize both current and future roles of exercise testing in clinical medicine.

INTRODUCTION {#sec1-2}
============

The need of the hour is to understand the different methods used worldwide to asses the patients exercise performance and response in clinical practice.

Clinical Exercise Testing (CET) is increasingly gaining importance in clinical medicine, by helping the clinician to objectively evaluate the physiological functions. The result helps to predict the outcome and mortality in different clinical circumstances.

COMMON METHODS TO ASSES EXERCISE RESPONSE AND PERFORMANCES IN CLINICAL PRACTICE {#sec1-3}
===============================================================================

Simple test are easily performed but limits physiological understanding.

More comprehensively performed tests may provide detail information and understanding but is costly and demanding. The clinician has to choose the type of test to perform for a particular patient

Commonly the following test is performed worldwide:- 6 min walk testShuttle Walk TestExercise Induced Bronchoconstriction TestCardiac Stress TestClinical Exercise Test (CET)

6 MINUTE WALK TEST {#sec1-4}
==================

It is a safe simple and practical test of sub maximal functional capacity, which measures the maximum distance walked by a subject in 6 minutes. Advantage of this test is that it provides an acceptable index of functional disability and correlates with oxygen uptake measured during comprehensive testing. This test gives very limited information regarding physiological contributors to activity related symptoms or about mechanism of exercise limitation. Currently this test is used in lung transplantation, lung volume reduction surgery, pulmonary rehabilitation and in predicting mortality in cardiac patients and patients with pulmonary vascular disorders.

SHUTTLE WALK TEST {#sec1-5}
=================

It measures the distance walked by a patient in a 10 meter course, being paced by an audio signals from a cassette. The intensity of exercise reached is comparable to test performed on a treadmill, as the walking speed is progressively increased until the patient reaches exhaustion. Modification of maximal SWT for determination of endurance performance -- similar to maximal and constant (sub maximal) cycle ergometry may be done.

EXERCISE INDUCED BRONCHOCONSTRICTION {#sec1-6}
====================================

In this physical activity triggers acute airway narrowing in patients with heightened airway responsiveness. In susceptible patients EIB typically occurs 5 to 10 minutes after exercise. and generally resolves in 20 to 30 minutes. In some clinical situation where bronchial challenge is unavailable or not diagnostic EIB should be undertaken.

Common protocols to be followed include exercise on treadmill or cycle ergometry at a workload of 60 %to 80% of predicted maximum or the intensity that will elicit a heart rate of 80% of predicted maximum for 6 to 8 minutes. The goal is to produce ventilation equal to those attained during activity to produce symptom of EIB.

15% percent decrease in FEV~1~ following exercise is diagnostic of EIB. And 10-15 % decrease in FEV~1~ would be suggestive of EIB.

CARDIAC STRESS TEST {#sec1-7}
===================

Common type of exercise testing, the primary purpose of which is diagnosis and management of myocardial infarction. Bruce protocol is commonly used and the single most reliable indication of ischemia is ST segment depression. During this test ECG and BP is measured, but the utility may be enhanced by concurrent measurement of ventilator parameters and respiratory gas exchange.

CLINICAL EXERCISE TESTING (CET) {#sec1-8}
===============================

CET involves the measurement of respiratory gas exchange i.e. oxygen uptake, carbon dioxide, minute ventilation, other variables while monitoring ECG, blood pressure, pulse oximetry and exertion perceived (Borg Scale) during a maximal symptom limited incremental test on a cycle ergo meter or treadmill. Simultaneous measurement of blood gasses and spirometry provides with more detail information on gas exchange and ventilation. CET provides a global assessment of integrative exercise responses which are not adequately reflected by measurement of individual organ system function on rest. Peak oxygen uptake remains the gold standard for exercise capacity.

It has tradionaly been undertaken with an incremental stepwise or ramp control protocol to exhaustion. In patients of COPD, acute response to an inhaled bronchodilator was assessed using various exercise tests. The authors found endurance time with a constant -- workload exercise (80% of maximal work rate)was the most responsive end point to the effect of bronchodilator showing 19% improvement in exercise duration time. Arterial blood gasses measured at 5 minute constant -- work exercise testing may give practical and cost effective alternative when arterial oxygen saturation, PaO2, alveolar --arterial oxygen pressure difference and ratio of physiological dead space to tidal volume are required.

INDICATIONS FOR EXERCISE TESTING IN CLINICAL PRACTICE {#sec1-9}
=====================================================

1.  Evaluation of Exercise Intolerence

2.  Evaluation of Unexplained exertional Dysponea

3.  Evaluation of patients of cardiovascular diseases

4.  Evaluation of Patients of respiratory diseases

    \- COPD

    \- ILD

    \- Pulmonary Vascular Diseases

    \- Cystic Fibrosis

5.  Preoperative evaluation

6.  Evaluation for transplantation and Lung Volume Reduction Surgeries

7.  Pulmonary Rehabilitation

8.  Impairment disability

[Table 1](#T0001){ref-type="table"} to [11](#T0011){ref-type="table"} illustrates the indication, contraindication and guidelines laid down by various international authorities for cardio pulmonary exercise testing in clinical setting.

CONCLUSION {#sec1-10}
==========

Cardiopulmonary exercise test is a helpful tool for evaluation of the disease and management in clinical practice and rapidly evolving in one of the important investigative and diagnostic test. There are different methods used in various clinical setting. The clinical exercise testing a simple and easy to perform test for a pulmonologist as compared to the other conducted tests and relatively more simpler and cost effective test, which needs to be more frequently used in our day to day clinical practice in relevant patients.

###### 

Overview of Cardiopulmonary Exercise Testing

  -------------------------------------------------------------------
  **Clinical Status Evaluation**
  Clinical diagnosis and reason(s) for CPET
  Health questionnaire (cardiopulmonary); physical activity profile
  Medical and occupational history and physical examination
  PFTs, CXR, ECG, and other appropriate laboratory tests.
  Determination of indications and contraindications for CPET
  ↓
  **Pretest Procedures**
  Abstain from smoking for at least 8 h before the test
  Refrain from exercise on the day of the test
  Medications as instructed
  Consent form
  ↓
  **Conduct of CPET**
  Laboratory procedures
     Quality control
     Equipment calibration
  Protocol Selection
     Incremental versus constant work rate; invasive versus
     nominvasive
  Patient preparation
     Familiarization
     12-lead ECG, pulse oximetry, blood pressure
     Arterial line (if warranted)
  Cardiopulmonary exercise testing
  ↓
  **Interpretation of CPET Results**
  Data processing
  Quality and consistency of results
  Comparison of results with approprate reference values
  Integrative approach to interpretation CPET results
  Preparation of CPET report
  -------------------------------------------------------------------

Definition of abbreviations : CPET = Cardiopulmonary exercise testing; CXR = chest X-ray; ECG; electrocardiogram; PFTs = pulmonary function tests.

###### 

Indications for Cardiopulmonary Exercise Testing

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Evaluation of exercise tolerance**
  Determination of functional impairment or capacity (peak Vo~2~)Determination of exercise-limiting factors and pathophysiologic mechanisms.
  **Evaluation of undiagnosed exercise intolerance**
  Assessing contribution of cardiac and pulmonary etiology in coexisting disease.Symptoms disproportionate to resting pulmonary and cardiac tests.Unexplained dyspnea when initial cardiopulmonary testing is nondiagnostic.
  **Evaluation of patients with cardiosvascular disease**
  Functional evaluation and prognosis in patients with heart failureSelection for cardiac transplantationExercise prescription and monitoring response to exercise training for cardiac rehabilitation.(special circumstance; i.e. pacemakers)
  **Evaluation of patients with respiratory disease**
  Functional impairement asessment (see specific clinical applications)Chronic obstructive pulmonary diseaseEstablishing exercise limitation(s) and assessing other potential contributing factors, especially occult heart disease (ischemia)Determination of magnitude of hypoxemia and for O~2~ prescriptionWhen objective determination of therapeutic intervention is necessary and not adequately addressed by standard pulmonary function testing.
  Interstitial lung diseasesDetection of early (occult) gas exchange abnormalitiesOverall assessment/ monitoring of pulmonary gas exchangeDetermination of magnitude of hypoxemia and for O~2~ prescriptionDetermination of potential exercise-limiting factorsDocumentation of therapeutic response to potentially toxic therapyPulmonary vascular disease (careful risk-benefit analysis required)Cystic fibrosisExercise-induced bronchospasm
  **Specific clinical applications**
  Preoperative evaluationLung resectional surgeryElderly patients undergoing major abdominal surgeryLung volume resectional surgery for emphysema (currently investigational)Exercise evaluation and prescription for pulmonary rehabilitationEvaluation for impairment-disabilityEvaluation for lung, heart-lung transplantationDefinition of abbreviations : Vo~2~ = oxygen consumption Reference 20
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Absolute and Relative Contraindications for Cardiopulmonary Exercise Test

  Absolute                                                                                                                                              Relative
  ----------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------
  Acute myocardial infarction (3-5 days)                                                                                                                Left main coronary stenosis or its equivalent
  Unstable angina                                                                                                                                       Moderate stenotic valvular heart disease
  Uncontrolled arrhythmias causing symptoms                                                                                                             Severe untreated arterial hypertension at rest
  or hemodynamic compromise                                                                                                                             (\> 200 mm Hg systolic, \> 120 mm Hg diastolic)
  Syncope                                                                                                                                               Tachyarrhythmias or bradyarrhymias
  Active endocardities                                                                                                                                  High-degree atrioventricular block
  Acute myocarditis or pericarditis                                                                                                                     Hypertrophic cardiomyopathy
  Symptomatic severe aortic stenosis                                                                                                                    Significant pulmonary hypertension
  Uncontrolled heart failure                                                                                                                            Advanced or complicated pregnancy
  Acute pulmonary embolus or pulmonary infarction                                                                                                       Electrolyte abnormalities
  Thrombosis of lower extremities                                                                                                                       Orthopedic impairment that compromises exercise performance
  Suspected dissecting aneurysm                                                                                                                         
  Uncontrolled asthma                                                                                                                                   
  Pulmonary edema                                                                                                                                       
  Room air desaturation at rest \< 85%[\*](#T000F1){ref-type="table-fn"}                                                                                
  Respiratory failure                                                                                                                                   
  Acute noncardiopulmonary disorder that may affect exercise performance or be aggrevated by exercise (i.e. infection, renal failure, thyrotoxicosis)   
  Mental impairment leading to inability to cooperate                                                                                                   

References 21, 22 and 23.

Exercise patient with supplemental O~2~.

###### 

Indications for Exercise Termination

  ------------------------------------------------------------------------------------------------
  Chest pain suggestive of ischemia
  Ischemic ECG changes
  Complex ectopy
  Second or third degree heart block
  Fall in systolic pressure \> 20 mm Hg from the highest value during the test
  Hypertension (\> 250 mm Hg systolic; \> 120 mm Hg diastolic)
  Severe desaturation : Spo~2~ \< 80% when accompanied by symptoms and signs of severe hypoxemia
  Sudden pallor
  Loss of coordination
  Mental confusion
  Dizziness or faintness
  Signs of respiratory failure
  ------------------------------------------------------------------------------------------------

Definition of abbreviations : ECG = electrocardiogram; Spo~2~ = arterial oxygen saturation as indicated by pulse oximetry.

References 22, 24, 25 and 26.

###### 

Usual Cardiopulmonary Exercise Response Patterns

  Measurement             Heart Failure                      COPD                             ILD                   Pulmonary Vascular Disease   Obesity                                         Deconditioned
  ----------------------- ---------------------------------- -------------------------------- --------------------- ---------------------------- ----------------------------------------------- ---------------------------
  Vo~2~max or Vo~2~peak   Decreased                          Decreased                        Decreased             Decreased                    Decreased for actual, normal for ideal weight   Decreased
  Anaerobic threshold     Decreased                          Normal/decreased indeterminate   Normal or decreased   Decreased                    Normal                                          Normal or decreased
  Peak HR                 Variable, usually normal in mild   Decreased, normal in mild        Decreased             Normal/slightly decreased    Normal/slightly decreased                       Normal/slightly decreased
  O~2~ pulse              Decreased                          Normal or decreased              Normal or increased   Normal                       Normal or increased                             Normal
  (VE/MVV) × 100          Normal or decreased                Increased                        Increased             Increased                    Normal                                          Normal
  VE/Vco~2~ (at AT)       Increased                          Increased                        Increased             Increased                    Normal                                          Normal
  VD/VT                   Increased                          Increased                        Increased             Increased                    Normal                                          Normal
  Pao~2~                  Normal                             Variable                         Decreased             Decreased                    Normal/may increase                             Normal
  P(A-a)O~2~              Usually normal                     Variably, usually increased      Increased             Increased                    May decrease                                    Normal

Definition of abbreviations : AT = anaerobic threshold; COPD = chronic obstructrutive pulmonary disease; HR = heart rate; ILD = interstitial disease; MVV = maximal voluntary ventilation; P(A-a)O~2~ = alveolar-arterial difference for oxygen pressure; VD/VT = ratio of physiologic dead space to tidal volume; VE = minute ventilation; Vco~2~ = carbon dioxide output; Vo~2~ max = maximal oxygen uptake; Vo~2~ peak = peak oxygen uptake. References **37**, **38** and **28**

Decreased, normal, and increased are with respect to the normal response.

###### 

Measurements during Cardiopulmonary Exercise Testing

  Measurements             Nominvasive                                                                  Invasive (Abgs)
  ------------------------ ---------------------------------------------------------------------------- -----------------------------------------------------------------------------
  External work            WR                                                                           
  Metabolic gas exchange   Vo~2~, Vco~2~, RER, AT                                                       Lactate
  Cardiovascular           HR, ECG, BP, O~2~ pulse                                                      
  Ventilatory              Va, Vr, fR                                                                   
  Pulmonary gas exchange   Spo~2~, Vr/Vco~2~, Vr/Vo~2~, P[ETO]{.smallcaps}~2~, P[ETCO]{.smallcaps}~2~   Pao^2^, Sao^2^, P([A]{.smallcaps}-a)O~2~, V[D]{.smallcaps}/V[T]{.smallcaps}
  Acid-base                                                                                             pH, Paco^2^, standard HCO~3~
  Symptoms                 Dyspnea, fatigue, chest pain                                                 

Definition of abbreviations : ABGs = Arterial blood gases; AT = anaerobic threshold; BP = Blood pressure; ECG = electrocardiogram; fR = respiratory frequency; HR = heart rate; P([A]{.smallcaps}-a)O~2~ = alveolar-arterial difference for oxygen pressure; Paco~2~ = arterial carbon dioxide pressure; Pao~2~ = arterial oxygen pressure; P[ET]{.smallcaps}-co~2~ = end-tidal Pco~2~; P[ET]{.smallcaps}o~2~, = end-tidal Po~2~; RER = respiratory exchange ratio; Sao~2~ = arterial oxygen saturation; Spo~2~ = arterial oxygen saturation as indicated by pulse oximetry; Vco~2~ = carbon dioxide output; V[E]{.smallcaps} = minute ventilation; V[D]{.smallcaps}/V[T]{.smallcaps} = ratio of physiologic dead space to tidal volume; Vo~2~ = oxygen uptake; V[T]{.smallcaps} = tidal volume; WR = work rate. 31

###### 

Suggested normal guidelines for interpretation of Cardiopulmonary Exercise Testing

  Variables                                  Criteria of Normality
  ------------------------------------------ ----------------------------------------------------------
  Vo~2~max or Vo~2~ peak                     \> 84% predicted
  Anaerobic threshold                        \> 40% Vo~2~max predicted; wide range of normal (40-80%)
  Heart rate (HR)                            HRmax \> 90% age predicted
  Heart rate reserve (HRR)                   HRR \< 15 beats/min
  Blood pressure                             \<220/90
  O~2~ pulse (Vo~2~/HR)                      \> 80%
  Ventilatory reserve (VR)                   MVV - Vemax: \> 11 or Vemax/MVV × 100 : \< 85%.
                                             Wide normal range : 72 + 15%
  Respiratory frequency (f[R]{.smallcaps})   \< 60 breaths/min
  V[E]{.smallcaps}/ Vco~2~ (at AT)           \< 34
  V[D]{.smallcaps}/V[T]{.smallcaps}          \< 0.28; \< 0.30 for age \> 40 years
  Pao~2~ \> 80 mm Hg                         
  P ([A]{.smallcaps}-a) O~2~                 \< 35 mm Hg

References 27, 28, 30, 35, 22 and 32

\* Maximum or peak cardiopulmonary responses except for anaerobic threshold and V[E]{.smallcaps}/Vco~2~ at AT.

###### 

Integrative approach to the interpretation of Cardiopulmonary exercise testing results

  ------ --------------------------------------------------------------------------------------------------------
  1\.    Determine reason(s) for CPET
  2\.    Review pertinent clinical and laboratory information (clinical status)
  3\.    Note overall quality of test, assessment of subject effort, and reasons for exercise cessation
  4\.    Identify key variables: initially Vo~2~, and then HR, VE, Sao~2~, and other measurements subsequently.
  5\.    Use tabular and graphic presentation of the data
  6\.    Pay attention to trending phenomena : submaximal through maximal responses.
  7\.    Compare exercise responses with appropriate reference values.
  8\.    Evaluate exercise limitation : physiologic versus nonphysiologic.
  9\.    Establish patterns of exercise responsess.
  10\.   Consider what conditions / clinical entities may be associated with these patterns.
  11\.   Correlae CPET results with clinical status.
  12\.   Generate CPET report.
  ------ --------------------------------------------------------------------------------------------------------

Definition of abbreviations : CPET = cardiopulmonary exercise testing; HR = heart rate; Sao~2~ = arterial oxygen saturation; Ve = minute ventilation; Vo~2~ = oxygen uptake.

Reference 27

###### 

Cardiopulmonary Exercise Response Patterns

  Measurement                         Heart Failure                      COPD                             ILD                   Pulmonary Vascular Disease   Obesity                                         Deconditioned
  ----------------------------------- ---------------------------------- -------------------------------- --------------------- ---------------------------- ----------------------------------------------- ---------------------------
  Vo~2~max or Vo~2~peak               Decreased                          Decreased                        Decreased             Decreased                    Decreased for actual, normal for ideal weight   Decreased
  Anaerobic threshold                 Decreased                          Normal/decreased indeterminate   Normal or decreased   Decreased                    Normal                                          Normal or decreased
  Peak HR                             Variable, usually normal in mild   Decreased, normal in mild        Decreased             Normal/slightly decreased    Normal/slightly decreased                       Normal/slightly decreased
  O~2~ pulse                          Decreased                          Normal or decreased              Normal or increased   Normal                       Normal or increased                             Normal
  (V[E]{.smallcaps}/MVV) × 100        Normal or decreased                Increased                        Increased             Increased                    Normal                                          Normal
  V[E]{.smallcaps}/Vco~2~ (at AT)     Increased                          Increased                        Increased             Increased                    Normal                                          Normal
  V[D]{.smallcaps}/V[T]{.smallcaps}   Increased                          Increased                        Increased             Increased                    Normal                                          Normal
  Pao~2~                              Normal                             Variable                         Decreased             Decreased                    Normal/may increase                             Normal
  P([A]{.smallcaps}-a)O~2~            Usually normal                     Variably, usually increased      Increased             Increased                    may decrease                                    Normal

Definition of abbreviations : AT = anaerobic threshold; COPD = chronic obstructrutive pulmonary disease; HR = heart rate; ILD = interstitial disease; MVV = maximal voluntary ventilation; P([A]{.smallcaps}-a)O~2~ = alveolar-arterial difference for oxygen pressure; V[D]{.smallcaps}/V[T]{.smallcaps} = ratio of physiologic dead space to tidal volume; V[E]{.smallcaps} = minute ventilation; Vco~2~ = carbon dioxide output; Vo~2~ max = maximal oxygen uptake; Vo~2~ peak = peak oxygen uptake. References 37, 36, 28

\* Decreased, normal, and increased are with respect to the normal response.

  --
  --

###### 

Selected reference values for maximal incremental cycle exercise test

  Variables               Equations[\*](#T000F3){ref-type="table-fn"}
  ----------------------- --------------------------------------------------
  Vo~2~, ml/min, male     W X \[50.75 − 0.372 (A)\]
  Vo~2~, ml/min, female   (W − 43) × \[22.78 − 0.17 (A)\]
  HR, beats/min           210 × 0.65 (A)[\*](#T000F3){ref-type="table-fn"}
  O~2~ pulse, ml/beat     Predicated Vo~2~ max/predicted HRmax
  Ve/MVV, %               ˜ 72 + 15
  AT, L/min (Vo~2~)       \> 40% Vo~2~ pred

Definition of abbreviations : AT = Anaerobic threshold; HR = heart rate; Ve = minute ventilation; Vo~2~ = oxygen uptake.

Data from Referenes 32, 33 and 34

Age (A) : years; height (H) : centimeters; weight (W), kilograms.

Predicted weight men : 0.79 × H − 60.7. Predicted weight women: 0.65 × H − 42.8. When actual weight \> predicted, the predicted weight should be used in the equations. Wasserman and colleagues introduced new corrections factors (34, 28), which have not yet been published in peer reviewed journals.

\^ See Lange-Andersen and coworkers (345).
